Displacement of One Drug by Another from Carrier or Receptor Sites
نویسندگان
چکیده
منابع مشابه
Coupling of catecholamine receptor from one cell with adenylate cyclase from another cell by cell fusion.
The experiments test the hypothesis that beta-adrenergic receptor is an independent unit that can be transferred from one adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4-6-1-1[ system to another. Turkey erythrocytes in which the catalytic activity of adenylate cyclase had been inactivated by N-ethylmaleimide or by heat contributed the beta-adrenergic receptor. Friend erythroleukemi...
متن کاملNeurons die one way or another
n page 987, Yu et al. identify a novel cell death pathway that bypasses mito-chondria. The results indicate that various strategies exist to kill off neurons. A lot of the killing of sympathetic neurons occurs in the first week after birth. During that paring period, ف 50% of sympathetic neurons die due to a lack of nerve growth factor (NGF). Neurons deprived of NGF in vitro die through the c...
متن کاملSeparating one organic from another
Env’s transmembrane domain revealed HIV-1’s envelope protein (Env) spans the viral membrane and grants the virus entry into host cells. Env is also the sole protein of HIV-1 that is targeted by antibodies, making it a key target for vaccine design. Dev et al. used nuclear magnetic resonance to determine an atomic-level structure of the membrane-spanning region of Env in a lipid bicelle. Env’s t...
متن کاملFrom One Crayfish to Another
study cultured stem cells from human embryos can proceed without violating the federal ban on embryo research in general. Since that decision, a great deal of excitement has arisen over the possibility that treatment of neurological disease may take a giant leap forward in the near future. The secrets to everything from preventing Alzheimer's Disease to reversing spinal cord damage may soon be ...
متن کاملPanitumumab, a monoclonal anti epidermal growth factor receptor antibody in colorectal cancer: another one or the one?
Panitumumab (Vectibix, Amgen, Inc.) is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). Panitumumab, formerly called ABX-EGF, was initially developed by Abgenix using the XenoMouse transgenic technology. This methodology is based on inactivating the mouse immunoglobulin genes that are replaced by a megabase gene containing the human heavy and n chain...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings of the Royal Society of Medicine
سال: 1965
ISSN: 0035-9157
DOI: 10.1177/003591576505811p202